VanEck Biotech ETF Holdings
BBH was created on 2011-12-20 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 369.72m in AUM and 26 holdings. BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.
Last Updated: 3 days, 17 hours ago
Last reported holdings - VanEck Biotech ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
AMGN
|
Amgen Inc | $53.6 million |
|
GILD
|
Gilead Sciences Inc | $52.4 million |
|
VRTX
|
Vertex Pharmaceuticals Inc | $29.0 million |
|
REGN
|
Regeneron Pharmaceuticals Inc | $26.7 million |
|
ARGX
|
argenx SE ADR | $18.6 million |
|
IQV
|
IQVIA Holdings Inc | $15.3 million |
|
INSM
|
Insmed Inc | $15.2 million |
|
ALNY
|
Alnylam Pharmaceuticals Inc | $14.6 million |
|
BIIB
|
Biogen Inc | $13.9 million |
|
NTRA
|
Natera Inc | $13.5 million |
|
UTHR
|
United Therapeutics Corp | $12.5 million |
|
ONC
|
BeOne Medicines Ltd ADR | $11.5 million |
|
MRNA
|
Moderna Inc | $11.2 million |
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $10.1 million |
|
ILMN
|
Illumina Inc | $8.8 million |
|
INCY
|
Incyte Corp | $8.0 million |
|
BNTX
|
BioNTech SE ADR | $7.7 million |
|
NBIX
|
Neurocrine Biosciences Inc | $7.0 million |
|
BMRN
|
BioMarin Pharmaceutical Inc | $5.0 million |
|
TECH
|
Bio-Techne Corp | $4.9 million |
|
CRL
|
Charles River Laboratories International Inc | $4.4 million |
|
ICLR
|
Icon PLC | $4.4 million |
|
QGEN
|
Qiagen NV | $4.2 million |
|
TEM
|
Tempus AI Inc Class A common stock | $3.2 million |
|
None
|
Us Dollar | $83160 |
Recent Changes - VanEck Biotech ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2026-03-24 |
RGEN
|
Repligen Corp | -31,987 |
| 2026-03-24 |
EXAS
|
Exact Sciences Corp | -87,035 |
| 2026-03-24 |
RVMD
|
Revolution Medicines Inc Ordinary Shares | 105,935 |
| 2026-01-08 |
QGEN
|
Qiagen NV | 105,882 |
| 2026-01-08 |
QGEN
|
Qiagen NV | -105,882 |
| 2025-09-23 |
SRPT
|
Sarepta Therapeutics Inc | -69,020 |
| 2025-09-23 |
TEM
|
Tempus AI Inc Class A common stock | 82,736 |
| 2025-09-23 |
UTHR
|
United Therapeutics Corp | 29,577 |
| 2025-07-03 |
-USD CASH-
|
-139,342 | |
| 2025-06-30 |
-USD CASH-
|
235,259 | |
| 2025-06-26 |
--
|
Other/Cash | None |
| 2025-06-24 |
--
|
Other/Cash | None |
| 2025-06-06 |
-USD CASH-
|
-490,795 | |
| 2025-06-05 |
-USD CASH-
|
490,795 | |
| 2025-05-31 |
--
|
Other/Cash | None |
| 2025-05-30 |
--
|
Other/Cash | None |
| 2025-05-27 |
--
|
Other/Cash | None |
| 2025-05-24 |
--
|
Other/Cash | None |
| 2025-05-22 |
--
|
Other/Cash | None |
| 2025-05-21 |
--
|
Other/Cash | None |
| 2025-05-19 |
--
|
Other/Cash | None |
| 2025-05-17 |
--
|
Other/Cash | None |
| 2025-05-16 |
--
|
Other/Cash | None |
| 2025-05-15 |
--
|
Other/Cash | None |
| 2025-05-01 |
-USD CASH-
|
-51,522 | |
| 2025-04-30 |
-USD CASH-
|
51,522 | |
| 2025-04-29 |
-USD CASH-
|
-51,355 | |
| 2025-04-28 |
-USD CASH-
|
51,355 | |
| 2025-04-26 |
-USD CASH-
|
-51,355 | |
| 2025-04-25 |
-USD CASH-
|
-51,355 | |
| 2025-04-21 |
-USD CASH-
|
51,355 | |
| 2025-04-18 |
-USD CASH-
|
-51,355 | |
| 2025-04-17 |
-USD CASH-
|
-51,355 | |
| 2025-04-14 |
-USD CASH-
|
51,355 | |
| 2025-04-12 |
-USD CASH-
|
-51,413 | |
| 2025-04-11 |
-USD CASH-
|
-51,379 | |
| 2025-04-07 |
-USD CASH-
|
51,099 | |
| 2025-04-05 |
-USD CASH-
|
-51,159 | |
| 2025-04-04 |
-USD CASH-
|
-51,159 | |
| 2025-04-03 |
-USD CASH-
|
-51,159 | |
| 2025-04-03 |
ITCI
|
Intra-Cellular Therapies Inc | 80,052 |
| 2025-04-02 |
ITCI
|
Intra-Cellular Therapies Inc | -80,052 |
| 2025-04-02 |
-USD CASH-
|
51,159 | |
| 2025-04-01 |
-USD CASH-
|
-128,707 | |
| 2025-03-31 |
-USD CASH-
|
128,707 | |
| 2025-03-29 |
-USD CASH-
|
-126,902 | |
| 2025-03-28 |
-USD CASH-
|
-368,027 | |
| 2025-03-27 |
-USD CASH-
|
368,027 | |
| 2025-03-24 |
CYTK
|
Cytokinetics Inc | -53,297 |
| 2025-03-24 |
ITCI
|
Intra-Cellular Therapies Inc | 80,052 |
| 2025-03-22 |
CYTK
|
Cytokinetics Inc | 53,297 |
| 2025-03-22 |
--
|
Other/Cash | None |
| 2025-03-22 |
ITCI
|
Intra-Cellular Therapies Inc | -80,052 |
| 2025-03-21 |
--
|
Other/Cash | None |
| 2025-03-21 |
-USD CASH-
|
-811,593 | |
| 2025-03-17 |
-USD CASH-
|
780,731 | |
| 2025-03-17 |
--
|
Other/Cash | None |
| 2025-03-15 |
--
|
Other/Cash | None |
| 2025-03-15 |
-USD CASH-
|
-780,731 | |
| 2025-03-10 |
-USD CASH-
|
779,949 | |
| 2025-03-08 |
-USD CASH-
|
-779,949 | |
| 2025-03-07 |
-USD CASH-
|
-779,949 | |
| 2025-03-07 |
SRPT US
|
Sarepta Therapeutics Inc | -69,532 |
| 2025-03-07 |
REGN US
|
Regeneron Pharmaceuticals Inc | -34,048 |
| 2025-03-07 |
VRTX
|
Vertex Pharmaceuticals Inc | 94,895 |
| 2025-03-07 |
RGEN US
|
Repligen Corp | -33,137 |
| 2025-03-07 |
QGEN US
|
Qiagen Nv | -150,536 |
| 2025-03-07 |
TECH US
|
Bio-Techne Corp | -106,991 |
| 2025-03-07 |
RGEN
|
Repligen Corp | 33,137 |
| 2025-03-07 |
QGEN
|
Qiagen NV | 150,536 |
| 2025-03-07 |
REGN
|
Regeneron Pharmaceuticals Inc | 34,048 |
| 2025-03-07 |
TECH
|
Bio-Techne Corp | 106,991 |
| 2025-03-07 |
SRPT
|
Sarepta Therapeutics Inc | 69,532 |
| 2025-03-07 |
VRTX US
|
Vertex Pharmaceuticals Inc | -94,895 |
| 2025-03-06 |
VRTX
|
Vertex Pharmaceuticals Inc | -94,895 |
| 2025-03-06 |
SRPT
|
Sarepta Therapeutics Inc | -69,532 |
| 2025-03-06 |
TECH
|
Bio-Techne Corp | -106,991 |
| 2025-03-06 |
RGEN
|
Repligen Corp | -33,137 |
| 2025-03-06 |
REGN
|
Regeneron Pharmaceuticals Inc | -34,048 |
| 2025-03-06 |
QGEN
|
Qiagen Nv | -150,536 |
| 2025-02-28 |
--
|
Other/Cash | None |
| 2025-02-28 |
-USD CASH-
|
350,878 | |
| 2025-02-27 |
--
|
Other/Cash | None |
| 2025-02-27 |
-USD CASH-
|
-341,131 | |
| 2025-02-26 |
-USD CASH-
|
341,131 | |
| 2025-02-26 |
--
|
Other/Cash | None |
| 2025-02-25 |
-USD CASH-
|
-341,316 | |
| 2025-02-25 |
--
|
Other/Cash | None |
| 2025-02-24 |
-USD CASH-
|
341,316 | |
| 2025-02-24 |
--
|
Other/Cash | None |
| 2025-02-22 |
--
|
Other/Cash | None |
| 2025-02-22 |
-USD CASH-
|
-341,331 | |
| 2025-02-21 |
--
|
Other/Cash | None |
| 2025-02-21 |
-USD CASH-
|
-341,331 | |
| 2025-02-18 |
--
|
Other/Cash | None |
| 2025-02-18 |
-USD CASH-
|
341,331 | |
| 2025-02-15 |
-USD CASH-
|
-341,331 | |
| 2025-02-15 |
--
|
Other/Cash | None |
| 2025-02-14 |
-USD CASH-
|
-341,331 | |
| 2025-02-14 |
--
|
Other/Cash | None |
| 2025-02-13 |
QGEN
|
Qiagen Nv | -155,058 |
| 2025-02-13 |
QGEN
|
Qiagen Nv | 155,058 |
| 2025-02-10 |
-USD CASH-
|
339,860 | |
| 2025-02-08 |
-USD CASH-
|
-339,860 | |
| 2025-02-07 |
-USD CASH-
|
-339,860 | |
| 2025-02-03 |
-USD CASH-
|
339,817 | |
| 2025-02-01 |
-USD CASH-
|
-458,373 | |
| 2025-01-31 |
-USD CASH-
|
458,373 | |
| 2025-01-30 |
-USD CASH-
|
-458,172 | |
| 2025-01-27 |
-USD CASH-
|
255,037 | |
| 2025-01-25 |
-USD CASH-
|
-255,037 | |
| 2025-01-24 |
-USD CASH-
|
-255,037 | |
| 2025-01-21 |
-USD CASH-
|
255,770 | |
| 2025-01-18 |
-USD CASH-
|
-255,770 | |
| 2025-01-17 |
-USD CASH-
|
-152,893 | |
| 2025-01-13 |
--
|
Other/Cash | None |
| 2025-01-13 |
-USD CASH-
|
153,375 | |
| 2025-01-11 |
-USD CASH-
|
-154,111 | |
| 2025-01-11 |
--
|
Other/Cash | None |
| 2025-01-10 |
--
|
Other/Cash | None |
| 2025-01-10 |
-USD CASH-
|
154,111 | |
| 2025-01-09 |
-USD CASH-
|
-151,342 | |
| 2025-01-08 |
-USD CASH-
|
-152,036 | |
| 2025-01-06 |
-USD CASH-
|
152,036 | |
| 2025-01-04 |
-USD CASH-
|
-152,036 | |
| 2025-01-03 |
-USD CASH-
|
-152,086 | |
| 2025-01-02 |
-USD CASH-
|
152,086 | |
| 2025-01-01 |
-USD CASH-
|
-274,025 | |
| 2025-01-01 |
ONC
|
BeiGene Ltd ADR | 38,367 |
| 2025-01-01 |
BGNE US
|
Beigene Ltd | -38,215 |
| 2024-12-31 |
BGNE
|
Beigene Ltd | -38,367 |
| 2024-12-30 |
-USD CASH-
|
273,284 | |
| 2024-12-27 |
--
|
Other/Cash | None |
| 2024-12-26 |
--
|
Other/Cash | None |
| 2024-12-25 |
--
|
Other/Cash | None |
| 2024-12-24 |
-USD CASH-
|
-3.0 million | |
| 2024-12-23 |
-USD CASH-
|
3.0 million | |
| 2024-12-21 |
-USD CASH-
|
-744,947 | |
| 2024-12-21 |
--
|
Other/Cash | None |
| 2024-12-20 |
--
|
Other/Cash | None |
| 2024-12-20 |
-USD CASH-
|
-416,952 | |
| 2024-12-16 |
-USD CASH-
|
416,842 | |
| 2024-12-16 |
--
|
Other/Cash | None |
| 2024-12-14 |
-USD CASH-
|
-416,842 | |
| 2024-12-14 |
--
|
Other/Cash | None |
| 2024-12-13 |
--
|
Other/Cash | None |
| 2024-12-13 |
-USD CASH-
|
-416,842 | |
| 2024-12-09 |
-USD CASH-
|
415,715 | |
| 2024-12-07 |
-USD CASH-
|
-523,659 | |
| 2024-12-02 |
--
|
Other/Cash | None |
| 2024-11-30 |
--
|
Other/Cash | None |
| 2024-11-22 |
--
|
Other/Cash | None |
| 2024-11-21 |
--
|
Other/Cash | None |
| 2024-11-20 |
--
|
Other/Cash | None |
| 2024-11-19 |
--
|
Other/Cash | None |
| 2024-11-19 |
-USD CASH-
|
-224,225 | |
| 2024-11-18 |
-USD CASH-
|
224,225 | |
| 2024-11-18 |
--
|
Other/Cash | None |
| 2024-11-16 |
--
|
Other/Cash | None |
| 2024-11-16 |
-USD CASH-
|
-224,225 | |
| 2024-11-15 |
-USD CASH-
|
-224,225 | |
| 2024-11-13 |
-USD CASH-
|
-224,225 | |
| 2024-11-11 |
-USD CASH-
|
221,824 | |
| 2024-11-09 |
-USD CASH-
|
-221,824 | |
| 2024-11-08 |
-USD CASH-
|
-221,824 | |
| 2024-11-04 |
-USD CASH-
|
221,824 | |
| 2024-11-01 |
-USD CASH-
|
-354,449 | |
| 2024-10-21 |
-USD CASH-
|
352,478 | |
| 2024-10-18 |
-USD CASH-
|
-352,478 | |
| 2024-10-17 |
-USD CASH-
|
352,478 | |
| 2024-10-16 |
-USD CASH-
|
-352,478 | |
| 2024-10-14 |
-USD CASH-
|
352,478 | |
| 2024-10-12 |
-USD CASH-
|
-352,478 | |
| 2024-10-10 |
-USD CASH-
|
-352,478 | |
| 2024-10-04 |
-USD CASH-
|
350,041 | |
| 2024-10-03 |
-USD CASH-
|
350,041 | |
| 2024-10-02 |
-USD CASH-
|
-350,041 | |
| 2024-09-30 |
-USD CASH-
|
480,963 | |
| 2024-09-28 |
-USD CASH-
|
-479,873 | |
| 2024-09-27 |
-USD CASH-
|
-479,873 | |
| 2024-09-26 |
-USD CASH-
|
479,873 | |
| 2024-09-25 |
--
|
Other/Cash | None |
| 2024-09-25 |
-USD CASH-
|
-128,917 | |
| 2024-09-23 |
CRSP
|
CRISPR Therapeutics AG | -81,125 |
| 2024-09-23 |
GRAL
|
GRAIL Inc | -26,016 |
| 2024-09-23 |
INSM
|
Insmed Inc | 127,024 |
| 2024-09-23 |
-USD CASH-
|
128,917 | |
| 2024-09-23 |
--
|
Other/Cash | None |
| 2024-09-21 |
INSM
|
Insmed Inc | -127,024 |
| 2024-09-21 |
GRAL
|
GRAIL Inc | 26,016 |
| 2024-09-21 |
CRSP
|
CRISPR Therapeutics AG | 81,125 |
| 2024-09-21 |
--
|
Other/Cash | None |
| 2024-09-21 |
-USD CASH-
|
-128,917 | |
| 2024-09-20 |
CRSP
|
Crispr Therapeutics Ag | -81,125 |
| 2024-09-20 |
GRAL
|
Grail Inc | -26,016 |
| 2024-09-20 |
INSM
|
Insmed Inc | 127,024 |
| 2024-09-18 |
-USD CASH-
|
355,907 | |
| 2024-09-18 |
--
|
Other/Cash | None |
| 2024-09-17 |
-USD CASH-
|
-355,907 | |
| 2024-09-17 |
--
|
Other/Cash | None |